Biotech · Private company
Triumvira Immunologics, Inc.
Track this companyFree. Adds Triumvira Immunologics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials21 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- TAC01-CLDN18.2Phase 2 · Metastatic Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- TAC01-HER2Phase 2 · HER2 Positive Gastric CancerClinicalTrials.gov · fetched Nov 12, 2026
- TAC01-HER2 plus pembrolizumabPhase 2 · HER2 Positive Gastric CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- TAC T-cells for the Treatment of Claudin 18.2 Positive Solid Tumors (TACTIC-3)PHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Aug 23, 2023ClinicalTrials.gov NCT05862324 · fetched Nov 12, 2026
- TAC T-cells for the Treatment of HER2-positive Solid TumorsPHASE1_PHASE2 · TERMINATED · started Apr 19, 2021ClinicalTrials.gov NCT04727151 · fetched Nov 12, 2026